Diabetes Discourse

Host: Janine Austin Clayton, MD

Guest: A. Paul Chous, MA, OD, FAAO, CDE

Guest: Anne Peters, MD

When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another key aspect that can unfortunately be easy to overlook is care collaboration. Featuring Dr. Janine Clayton, Dr. A. Paul Chous, and Dr. Anne Peters, this discussion will focus on how providers can work together to optimize patients’ eye health and minimize their risk of vision loss from diabetic retinopathy and diabetic macular edema.

Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

Host: Anne Peters, MD

Guest: Thomas W. Gardner, MD, MS

Guest: Diana Shechtman, OD, FAAO

Unfortunately, there are many factors that can contribute to a patient’s risk for vision-threatening complications and vision loss due to diabetes. Explore those factors with Dr. Anne Peters, Dr. Thomas Gardner, and Dr. Diana Shechtman, who also discuss how endocrinologists and primary care providers can work together with eye care professionals to actively optimize vision outcomes for patients at risk for diabetic retinopathy and diabetic macular edema.

Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

Guest: Michael H. Davidson, MD

Tune in as Dr. Michael Davidson, a preventive cardiologist from the University of Chicago Pritzker School of Medicine, outlines what a diabetes cardiovascular outcomes trial (CVOT) is, the differences between CVOTs and glycemic efficacy trials, and how these studies are designed and assessed.

US19HCP00067 July 2019

Host: Jennifer Caudle, DO

Guest: Christie Ballantyne, MD

With the number of patients with both type 2 diabetes and established cardiovascular disease on the rise, a personalized patient approach to treating these two conditions is now more important than ever. Joining Dr. Jennifer Caudle to discuss the role of the cardiologist in managing patients with type 2 diabetes is Dr. Christie Ballantyne.

US18VZ00285 January 2019

Host: Jennifer Caudle, DO

Guest: Mikhail Kosiborod, MD

Guest: Christie Ballantyne, MD

Since type 2 diabetes and cardiovascular disease often go hand in hand, having a care collaboration plan in place is essential in managing these conditions. Here to discuss both the challenges and opportunities that arise when collaborating patient care are cardiologists Dr. Mikhail Kosiborod and Dr. Christie Ballantyne.

US18VZ00286 January 2019

Host: Shira Johnson, MD

Guest: Anne Peters, MD

Guest: Donna Miller, MSN, FNP-C, CDE

Guest: Jana Conley

This activity explores new and emerging treatments for type 1 diabetes, including a dual sodium glucose transporter 1/2 inhibitor, and provides both clinician and patient perspectives on their use.

Host: Rishi P. Singh, MD

Guest: Arshad Khanani, MD

Guest: Ehud Ur, MD

Guest: David Boyer, MD

Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options for efficient, accurate and reproducible diagnosis and monitoring of ocular conditions. Likewise, diabetes management guidelines and strategies, including pharmacologic treatments and devices, have also evolved, underscoring the importance of cross-disciplinary education and communication, as well as a higher level of participation from the patient. Treatment and management strategies need to be determined that lower the burden of illness, lower the burden of treatment, and enhance outcomes and overall quality of life for patients.

Host: Rishi P. Singh, MD

Guest: Arshad Khanani, MD

Guest: Ehud Ur, MD

Guest: David Boyer, MD

Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options for efficient, accurate and reproducible diagnosis and monitoring of ocular conditions. Likewise, diabetes management guidelines and strategies, including pharmacologic treatments and devices, have also evolved, underscoring the importance of cross-disciplinary education and communication, as well as a higher level of participation from the patient. Treatment and management strategies need to be determined that lower the burden of illness, lower the burden of treatment, and enhance outcomes and overall quality of life for patients.

Host: John J. Russell, MD

Guest: John (Jack) L. Leahy, MD

Diabetes is a major global health emergency, affecting approximately 415 million adults and contributing to five million deaths each year. Cardiovascular disease is a serious complication of type 2 diabetes mellitus (T2DM), contributing to the majority of morbidity and mortality in this population. In recent years, the cardiovascular impact of anti-diabetes medications has become the focus of research. Recent findings from long-term, large-scale, cardiovascular outcome trials of antihyperglycemic agents have shown that some T2DM treatments can provide cardiometabolic benefits beyond glycemic control and may open the door for more successful management. As a value added-resource, a specialized toolkit will also be included as a supplement to the webcast. The toolkit will provide reference materials including key publications for a deeper review of the data for clinicians as well as helpful information and resources for families and caregivers.

Host: John J. Russell, MD

Guest: Anne Peters, MD, CDE

Many patients with type 2 diabetes mellitus cannot be controlled with standard insulin agents due to obesity, insulin resistance, high risk of hypoglycemia, low adherence due to high injection burden, and the need for frequent glucose monitoring. Drs. Peters and Russell will review patient cases, and share practical information on concentrated insulins, including criteria for selection, switching strategies and dosing regimens, providing true practice-based learning particularly for clinicians in different geographic locations with high incidence rates of diabetes.